Systemic Lupus Erythematosus
Mostrando 1-12 de 1286 artigos, teses e dissertações.
-
1. Como a modificação da dieta pode auxiliar pacientes com Lúpus?
Pacientes com Lúpus Eritematoso Sistêmico (LES) tendem a apresentar triglicerídeos e pressão arterial elevados, aumentando os riscos para desenvolvimento de uma síndrome metabólica (SM). Um estudo mostrou que quando avaliada a presença de SM associada a pacientes com LES, percebeu-se uma prevalência de 26%, podendo variar e 18 a 34%, de acordo com
Núcleo de Telessaúde Maranhão HU-UFMA. Publicado em: 12/06/2023
-
2. Quais são as causas e qual é a investigação inicial de plaquetopenia assintomática?
Plaquetopenia é um achado frequente no hemograma, e nem sempre significa presença de alguma doença. Sempre que não houver uma causa conhecida, e as plaquetas estiverem acima de 50.000 células/mm³, deve-se inicialmente confirmar se a plaquetopenia é real repetindo o exame, para excluir erro laboratorial ou agregação in vitro. Alguns indivíduos t�
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
3. Predictors of pain catastrophizing in women with systemic lupus erythematosus
SUMMARY OBJECTIVE: The aim of this study was to identify predictive factors associated with pain catastrophizing in women with systemic lupus erythematosus (SLE). METHODS: A total of 104 volunteered women with a diagnosis of systemic lupus erythematosus participated in the study. Pain Catastrophizing Scale, Body Awareness Questionnaire, Tampa Scale of Kine
Revista da Associação Médica Brasileira. Publicado em: 2022
-
4. Risk factors associated with infections in pregnant women with systemic lupus erythematosus
SUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregn
Revista da Associação Médica Brasileira. Publicado em: 2022
-
5. Comment on “Nutritional aspects and cardiovascular risk in systemic lupus erythematosus”
Revista da Associação Médica Brasileira. Publicado em: 2022
-
6. Quality of Life of Pregnant Women with Systemic Lupus Erythematosus
Resumo Objetivo Investigar a qualidade de vida (QV) de gestantes com lúpus eritematoso sistêmico (LES), em acompanhamento ambulatorial pré-natal de alto risco, durante o terceiro trimestre de gestação. Métodos Foi realizado um estudo observacional descritivo em ambulatório de prénatal de alto risco. Asmulheres emacompanhamento pré-natal no terce
Revista Brasileira de Ginecologia e Obstetrícia. Publicado em: 2022
-
7. Mortality in the Elderly Due to Cerebrovascular Disease
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of ex
Int. J. Cardiovasc. Sci.. Publicado em: 2021-04
-
8. Research and Publication in Brazil: Where we are and Where we Head to
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of ex
Int. J. Cardiovasc. Sci.. Publicado em: 2021-04
-
9. Effects of Chloroquine and Hydroxychloroquine on the Cardiovascular System - Limitations for Use in the Treatment of COVID-19
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of ex
Int. J. Cardiovasc. Sci.. Publicado em: 2021-04
-
10. Association between pemphigus and systemic lupus erythematosus: a systematic review and meta-analysis,
Abstract Small vessel vasculitis with anti-proteinase antibodies 3 is an atypical clinical presentation of tuberculosis. The authors present the case of a 47-year-old male patient, with palpable purpura and palmoplantar hemorrhagic blisters, with subsequent dissemination. He presented severe pulmonary symptoms with cavitation, fever, hemoptysis, and high lev
An. Bras. Dermatol.. Publicado em: 2021-03
-
11. New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre
Abstract Objective: To determine pregnancy outcomes in women with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine in a tertiary center. Methods: A retrospective study involving pregnant women with SLE who had antenatal follow-up and delivery in between 1 January 2007 and 1 January 2017. All participants were retrospectively enro
Rev. Bras. Ginecol. Obstet.. Publicado em: 2020-11
-
12. Case for diagnosis. Infiltrated areas on the trunk,
Abstract Leprosy is an infectious disease with chronic evolution, caused by Mycobacterium leprae, an acid-fast bacillus that mainly affects the skin and peripheral nervous tissue. Many of the clinical manifestations of leprosy can mimic connective tissue diseases. The authors present the case of a 49-year-old woman who had been treated for four years for sys
An. Bras. Dermatol.. Publicado em: 2020-10